Why the study?
Does the integration of CD56-based risk stratification and novel chemotherapy protocols improve prognosis in local nonmetastatic Ewing sarcoma?
Does the integration of CD56-based risk stratification and novel chemotherapy protocols improve prognosis in local nonmetastatic Ewing sarcoma?
This is the authors' abstract. We don't add key points for this paper.
The study by Whelan and colleagues showed that addition of busulfan and melphalan conditioning and autologous stem cell rescue to conventional EURO-E.W.I.N.G STUDY chemotherapy in local nonmetastatic Ewing sarcoma improves prognosis. However, almost 30% of these study patients will have relapsed before this stage of therapy is reached, and 78% of his patients were at high risk because of inadequate response to the initial chemotherapy given. Further improvement could be achieved by the integration of other novel advances with this approach. Ash and colleagues have shown that the separation of such cases into high- and low-risk groups by using CD56 negativity of the tumor cells is an improvement over current methods with a 100% 10-year progression-free survival in CD56- nonpelvic local isolated Ewing sarcoma patients. Their patients were treated on the SCMCIE 94 protocol, associated with no relapses before 30 months in 24 consecutive patients independent of the CD status. Integration of these novel approaches in diagnosis and treatment would allow truly high-risk patients, who would benefit from the procedure, to reach the busulfan and melphalan stage of therapy and delineate those patients who can be cured without such therapy. Details of the SCMCIE 94 protocol are given and the possible reasons for the different relapse patterns are discussed.
Answers are grounded in this paper and cite their sources.
Integrating novel diagnostic markers like CD56 with intensive chemotherapy protocols promises to improve risk stratification and outcomes in local Ewing sarcoma.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: